vs

Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and Piedmont Realty Trust, Inc. (PDM). Click either name above to swap in a different company.

Piedmont Realty Trust, Inc. is the larger business by last-quarter revenue ($143.3M vs $77.6M, roughly 1.8× Bioceres Crop Solutions Corp.). Bioceres Crop Solutions Corp. runs the higher net margin — -9.6% vs -31.4%, a 21.8% gap on every dollar of revenue. On growth, Piedmont Realty Trust, Inc. posted the faster year-over-year revenue change (0.4% vs -16.8%). Over the past eight quarters, Piedmont Realty Trust, Inc.'s revenue compounded faster (0.0% CAGR vs -8.4%).

Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.

Piedmont Realty Trust, Inc. is a publicly traded real estate investment trust (REIT) that owns, operates, and invests in high-quality office properties primarily located in high-growth metropolitan areas across the United States. It serves corporate tenants across multiple industry sectors including technology, professional services, and healthcare, and pursues stable long-term returns for stakeholders via strategic property management and portfolio optimization.

BIOX vs PDM — Head-to-Head

Bigger by revenue
PDM
PDM
1.8× larger
PDM
$143.3M
$77.6M
BIOX
Growing faster (revenue YoY)
PDM
PDM
+17.2% gap
PDM
0.4%
-16.8%
BIOX
Higher net margin
BIOX
BIOX
21.8% more per $
BIOX
-9.6%
-31.4%
PDM
Faster 2-yr revenue CAGR
PDM
PDM
Annualised
PDM
0.0%
-8.4%
BIOX

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
BIOX
BIOX
PDM
PDM
Revenue
$77.6M
$143.3M
Net Profit
$-7.4M
$-45.0M
Gross Margin
46.8%
Operating Margin
9.3%
Net Margin
-9.6%
-31.4%
Revenue YoY
-16.8%
0.4%
Net Profit YoY
-20.2%
-27.9%
EPS (diluted)
$-0.12
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIOX
BIOX
PDM
PDM
Q1 26
$143.3M
Q4 25
$142.9M
Q3 25
$77.6M
$139.2M
Q2 25
$140.3M
Q1 25
$60.6M
$142.7M
Q4 24
$98.8M
$143.2M
Q3 24
$93.3M
$139.3M
Q2 24
$143.3M
Net Profit
BIOX
BIOX
PDM
PDM
Q1 26
$-45.0M
Q4 25
$-43.2M
Q3 25
$-7.4M
$-13.5M
Q2 25
$-16.8M
Q1 25
$-1.6M
$-10.1M
Q4 24
$605.2K
$-30.0M
Q3 24
$-6.2M
$-11.5M
Q2 24
$-9.8M
Gross Margin
BIOX
BIOX
PDM
PDM
Q1 26
Q4 25
Q3 25
46.8%
Q2 25
Q1 25
39.4%
Q4 24
42.0%
Q3 24
40.2%
Q2 24
Operating Margin
BIOX
BIOX
PDM
PDM
Q1 26
Q4 25
Q3 25
9.3%
Q2 25
Q1 25
1.5%
Q4 24
14.5%
Q3 24
2.5%
Q2 24
Net Margin
BIOX
BIOX
PDM
PDM
Q1 26
-31.4%
Q4 25
-30.3%
Q3 25
-9.6%
-9.7%
Q2 25
-12.0%
Q1 25
-2.6%
-7.1%
Q4 24
0.6%
-20.9%
Q3 24
-6.6%
-8.3%
Q2 24
-6.8%
EPS (diluted)
BIOX
BIOX
PDM
PDM
Q1 26
$-0.10
Q4 25
$-0.34
Q3 25
$-0.12
$-0.11
Q2 25
$-0.14
Q1 25
$-0.02
$-0.08
Q4 24
$0.00
$-0.25
Q3 24
$-0.10
$-0.09
Q2 24
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIOX
BIOX
PDM
PDM
Cash + ST InvestmentsLiquidity on hand
$15.5M
$2.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$288.3M
$1.5B
Total Assets
$734.9M
$4.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIOX
BIOX
PDM
PDM
Q1 26
$2.3M
Q4 25
$731.0K
Q3 25
$15.5M
$3.0M
Q2 25
$3.3M
Q1 25
$38.5M
$2.9M
Q4 24
$29.2M
$109.6M
Q3 24
$32.3M
$133.6M
Q2 24
$138.5M
Total Debt
BIOX
BIOX
PDM
PDM
Q1 26
Q4 25
$2.2B
Q3 25
$2.2B
Q2 25
$2.2B
Q1 25
$2.2B
Q4 24
$2.2B
Q3 24
$2.2B
Q2 24
$2.2B
Stockholders' Equity
BIOX
BIOX
PDM
PDM
Q1 26
$1.5B
Q4 25
$1.5B
Q3 25
$288.3M
$1.5B
Q2 25
$1.5B
Q1 25
$345.0M
$1.6B
Q4 24
$346.3M
$1.6B
Q3 24
$346.0M
$1.6B
Q2 24
$1.7B
Total Assets
BIOX
BIOX
PDM
PDM
Q1 26
$4.0B
Q4 25
$4.0B
Q3 25
$734.9M
$4.0B
Q2 25
$4.0B
Q1 25
$798.2M
$4.0B
Q4 24
$835.2M
$4.1B
Q3 24
$827.3M
$4.1B
Q2 24
$4.2B
Debt / Equity
BIOX
BIOX
PDM
PDM
Q1 26
Q4 25
1.49×
Q3 25
1.43×
Q2 25
1.41×
Q1 25
1.40×
Q4 24
1.40×
Q3 24
1.36×
Q2 24
1.34×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIOX
BIOX
PDM
PDM
Operating Cash FlowLast quarter
$14.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
110.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIOX
BIOX
PDM
PDM
Q1 26
Q4 25
$140.6M
Q3 25
$14.4M
$35.8M
Q2 25
$50.1M
Q1 25
$23.3M
$3.7M
Q4 24
$-5.4M
$198.1M
Q3 24
$5.2M
$42.9M
Q2 24
$66.8M
Capex Intensity
BIOX
BIOX
PDM
PDM
Q1 26
110.3%
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Cash Conversion
BIOX
BIOX
PDM
PDM
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-8.85×
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons